Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-14

Clinical Trial Update: Treatment of Negative Symptoms and Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial investigating treatment for negative symptoms in schizophrenia conducted by University Hospital, Montpellier.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED